Baseimmune

London, United Kingdom

Baseimmune is a biotech startup founded to create the next generation of vaccines.

$11.4M raised

Feb 2024

Series A

Top Investors

Maki.vcCherry VenturesIQ CapitalHoxton VenturesCreator Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Baseimmune raised?

Baseimmune has raised $11.4M in total funding. The most recent round was Series A. The last funding was announced in February 2024.

Who are Baseimmune's investors?

Baseimmune's investors include Maki.vc, Cherry Ventures, IQ Capital, Hoxton Ventures, Creator Fund.

Where is Baseimmune headquartered?

Baseimmune is headquartered in London, United Kingdom.

What does Baseimmune do?

Baseimmune is a biotech startup founded to create the next generation of vaccines.

What stage is Baseimmune at?

Baseimmune is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 26, 2024.

MLA

"Baseimmune — Funding & Investors." VCBacked, February 26, 2024, https://www.vcbacked.co/company/baseimmune. Accessed June 4, 2026.

APA

VCBacked. (2024). Baseimmune — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/baseimmune

Wikipedia (cite web)

{{cite web |title=Baseimmune — Funding & Investors |url=https://www.vcbacked.co/company/baseimmune |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 26, 2024.